BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7881702)

  • 1. Thrombin and platelet inhibition with low-dose calcium-heparin in comparison with ASA in patients with peripheral arterial occlusive disease at Leriche-Fontaine IIb class.
    Allegra C; Pollari G; Carioti B; Sardina M
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):646-51. PubMed ID: 7881702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-month therapy with calcium-heparin in comparison with ticlopidine in patients with peripheral arterial occlusive disease at Leriche-Fontaine IIb class.
    Andreozzi GM; Signorelli SS; Cacciaguerra G; Di Pino L; Martini R; Monaco S; Buttò G; Sardina M
    Angiology; 1993 Apr; 44(4):307-13. PubMed ID: 8457082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Physical training and low-dose heparin-calcium in patients suffering from chronic obliterating arteriopathy of the lower limbs with intermittent claudication].
    Cina G; Vernich M; Campisi C; Cascone C; Ofria F; Leopardi N; Maniscalco G; Moricca N; Ceccarelli V; Paolicelli D; Carbone D
    Minerva Cardioangiol; 1996 Apr; 44(4):179-85. PubMed ID: 8767599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of the acetylosalicyd acid (ASA) and ticlopidine therapy on clinical condition and parameters of blood platelets in patients with peripheral arterial occlusive disease (PAOD)].
    Leo W; Westrych R; Bissinger A; Okraszewski J; Baj Z
    Pol Merkur Lekarski; 2007 Nov; 23(137):335-9. PubMed ID: 18361314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of controlled vascular training on the pain free walking distance and plasmaviscosity in patients suffering from peripheral arterial occlusive disease.
    Häfner HM; Jünger I; Geyer A; Jünger M; Strölin A
    Clin Hemorheol Microcirc; 2009; 41(1):73-80. PubMed ID: 19136745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcutaneous oxygen pressure as predictive parameter for ulcer healing in endstage vascular patients treated with spinal cord stimulation.
    Claeys LG; Horsch S
    Int Angiol; 1996 Dec; 15(4):344-9. PubMed ID: 9127776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication.
    Mangiafico RA; Malatino LS; Santonocito M; Messina R; Attinà T; Dell'Arte S; Sarnataro F
    Int J Clin Pharmacol Ther; 1999 Jul; 37(7):347-51. PubMed ID: 10442509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS).
    Tsuchida H; Shigematsu H; Ishimaru S; Iwai T; Akaba N; Umezu S
    Int Angiol; 2006 Sep; 25(3):287-92. PubMed ID: 16878078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty.
    Mueller MR; Salat A; Stangl P; Murabito M; Pulaki S; Boehm D; Koppensteiner R; Ergun E; Mittlboeck M; Schreiner W; Losert U; Wolner E
    Thromb Haemost; 1997 Sep; 78(3):1003-7. PubMed ID: 9308744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV
    Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous heparin activity is decreased in peripheral arterial occlusive disease.
    Shankar VK; Handa A; Hands L
    J Vasc Surg; 2008 May; 47(5):1033-8. PubMed ID: 18328667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and circulatory effects of Iloprost either administered for 1 week or 4 weeks in patients with peripheral obstructive arterial disease at Leriche-Fontaine stage III.
    Arosio E; Sardina M; Prior M; De Marchi S; Zannoni M; Bianchini C
    Eur Rev Med Pharmacol Sci; 1998; 2(2):53-9. PubMed ID: 10229559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal walking distance following exercise treatment in patients with arterial occlusive disease.
    Rosetzsky A; Struckmann J; Mathiesen FR
    Ann Chir Gynaecol; 1985; 74(6):261-4. PubMed ID: 4096478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propionyl-L-carnitine in Leriche-Fontaine stage II peripheral arterial obstructive disease.
    Allegra C; Antignani PL; Schachter I; Koverech A; Messano M; Virmani A
    Ann Vasc Surg; 2008; 22(4):552-8. PubMed ID: 18502605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of the effectiveness of physical training with parenteral drug therapy in Fontaine stage IIb peripheral arterial occlusive disease].
    Streminski JA; de la Haye R; Rettig K; Kuntz G
    Vasa; 1992; 21(4):392-402. PubMed ID: 1485475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of the effects of low-dose calcium-heparin in patients with peripheral arterial disease and claudication. Italian CAP Study Group.
    Antonicelli R; Sardina M; Scotti A; Bonizzoni E; Paciaroni E
    Am J Med; 1999 Sep; 107(3):234-9. PubMed ID: 10492316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treadmill exercise-induced release of endothelin-1 in patients with peripheral arterial occlusive disease at Fontaine stage IIb.
    Mangiafico RA; Malatino LS; Spada RS; Santonocito M; Messina R; Dell'Arte S; Attinà T
    Int Angiol; 2000 Mar; 19(1):14-7. PubMed ID: 10853680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcutaneous oxygen tension (TcPO2) in the testing period of spinal cord stimulation (SCS) in critical limb ischemia of the lower extremities.
    Petrakis IE; Sciacca V
    Int Surg; 1999; 84(2):122-8. PubMed ID: 10408282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of cutaneous necrosis risk in peripheral arterial diseases].
    D'Eri A; Martini R; Cordova RM; Trevisan G; Andreozzi GM
    Minerva Cardioangiol; 2002 Jun; 50(3):239-44. PubMed ID: 12107403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the efficacy of propionyl-L-carnitine versus pulsed muscular compressions in diabetic and non-diabetic patients affected by obliterating arteriopathy Leriche stage II.
    Riccioni C; Sarcinella R; Palermo G; Izzo A; Liguori M; Koverech A; Messano M; Virmani A
    Int Angiol; 2008 Jun; 27(3):253-9. PubMed ID: 18506129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.